Welcome to our dedicated page for Foresight Autonomous Hldgs news (Ticker: FRSX), a resource for investors and traders seeking the latest updates and insights on Foresight Autonomous Hldgs stock.
Foresight Autonomous Holdings Ltd. develops advanced 3D perception systems and cellular-based applications for safety and mobility use cases. Through controlled subsidiaries including Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd., the company works on in-line-of-sight vision systems and beyond-line-of-sight accident-prevention solutions based on stereo vision, 3D perception and V2X technologies.
Recurring FRSX news covers proof-of-concept agreements, smart-mobility collaborations, public-transit and urban V2X projects, and technical updates for Eye-Net collision-prevention systems. Company updates also include capital-structure items such as ADS matters, shareholder voting, governance disclosures, material agreements, and operating or financial results.
Foresight (Nasdaq: FRSX) signed a Final Development and Commercialization Agreement with a Japanese in-vehicle AI device manufacturer and Cornes to integrate its ScaleCam 3D perception software into the manufacturer’s flagship AI systems.
The deal includes a design freeze and transfer to production, targeting serial production in early 2027. It is expected to generate up to $10.5 million in potential software license revenue from about 400,000 units between 2027 and 2030, with a high gross margin model and recurring license fees. The parties also aim to expand the joint solution to Japanese and global OEMs. Foresight also recently entered a non-binding term sheet for a potential strategic equity investment and technology integration with VisionWave (Nasdaq: VWAV), subject to conditions.
Foresight (Nasdaq/TASE: FRSX) signed a non-binding term sheet with VisionWave (Nasdaq: VWAV) to integrate Foresight’s visible/IR and neuromorphic sensors into VisionWave’s defense and autonomous platforms. VisionWave may acquire 45%–51% of Foresight for approximately $17.5 million in VisionWave stock in staged closings. The deal contemplates initial two board seats for VisionWave, definitive agreements within 30 days of the April 19, 2026 term sheet, and closing subject to due diligence, regulatory, exchange and shareholder approvals including Nasdaq requirements.
Foresight (NASDAQ/TASE: FRSX) majority-owned subsidiary Eye-Net signed a non-binding LOI with the City of Muntinlupa to cooperate on smart urban mobility, collision prediction and cellular-based V2X testing in the Manila metro.
The LOI contemplates a live demo followed by a six-month pilot engaging at least 8,000 road users, with possible SDK integration into a Muntinlupa city mobile app upon successful completion and meeting predefined KPIs to enable collision-avoidance alerts and emergency services for residents.
Foresight (Nasdaq/TASE: FRSX) signed an agreement with a leading European car manufacturer to run a Proof-of-Concept (POC) validating its stereo-vision AI system for off-road driving.
The POC will be installed on the vehicle platform, demonstrated in daylight and low-light, and—if validated—may lead to a joint development phase adding automatic field classification and a three-level output.
Foresight (Nasdaq/TASE: FRSX) entered a non-binding term sheet with VisionWave (Nasdaq: VWAV) for a strategic equity investment of up to $17.5 million, valuing Foresight at approximately $35 million (about three times current market value).
The proposed deal would transfer up to 51% (not less than 45%) of Foresight's issued share capital to VisionWave and refocus commercial efforts toward defense, military and homeland security markets. Closing remains subject to due diligence, approvals, and definitive agreements.
Foresight (Nasdaq & TASE: FRSX) reported fourth-quarter and full-year 2025 results on March 26, 2026, highlighting commercial progress and partner milestones alongside continued losses. Key items include a $5.0M India grant project, Eye-Net's $3.0M financing at a $55M valuation, and a Japan commercialization agreement with initial revenues expected.
Fourth-quarter revenue fell 39.6% to $61,000; cash totaled $6.3M and GAAP full-year net loss was $12.1M.
Foresight (Nasdaq:TASE: FRSX) majority-owned subsidiary Eye-Net completed a large-scale live trial of the SafeCycloMove V2X collision-prevention project in Bordeaux on March 13, 2026.
The trial demonstrated positioning accuracy, ultra-low latency, stable real-time communication and full scalability under heavy load, and the parties are in active commercial discussions to pursue joint commercialization.
Foresight (Nasdaq/TASE: FRSX) signed a development and commercialization agreement with a leading Japanese manufacturer and distributor Cornes Technologies to integrate its 3D perception systems into smart-city and road-safety solutions. Development runs through Q2 2027 with initial revenue of ~$250,000 and conservative potential revenue of $3.6 million by 2030. Projects use dual stereoscopic visible-light and thermal cameras plus AI for real-time lane, hazard and traffic behavior detection to support patrol/service vehicles and smart-city monitoring.
Foresight (Nasdaq/TASE: FRSX) will change its American Depositary Share ratio from 1 ADS = 30 ordinary shares to 1 ADS = 90 ordinary shares, effective February 26, 2026. ADS holders will exchange three existing ADSs for one new ADS; uncertificated ADSs in DRS/DTC will convert automatically.
The ADSs will retain the FRSX ticker on Nasdaq with a new CUSIP. The change is intended to help maintain Nasdaq compliance; no change to ordinary shares, ownership percentages, or voting power.
Foresight (NASDAQ and TASE: FRSX) reported that its majority-owned subsidiary Eye-Net, together with Renault Group and Orange, completed a large-scale live trial of the SafeCycloMove “Collision Prevention” project in Bordeaux on Feb 9, 2026.
The trial demonstrated positioning accuracy, ultra-low latency, stable real-time communication and full scalability under heavy load, integrating Eye-Net’s SDK into multiple apps for buses and cyclists. Eye-Net said these results support ongoing commercial discussions to pursue joint commercialization.